S64 Appoints Shawn Ko as Head of South Korea
September 10, 2024 05:54 ET
|
S64
LONDON and SEOUL, South Korea, Sept. 10, 2024 (GLOBE NEWSWIRE) -- S64, the leading alternatives fintech and solutions partner to the wealth management industry, has today announced the appointment...
Adi Dagan Joins Optimove as Senior Director of Partnerships
September 09, 2024 14:09 ET
|
Optimove
NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Optimove, the #1 CRM Marketing Solution for iGaming and Sports Betting, is pleased to announce the appointment of Adi Dagan as Senior Director of...
Marimaca Appoints Oscar Valenzuela as VP Project and Alexis Muñoz as VP Project Execution
September 09, 2024 07:00 ET
|
Marimaca Copper Corp.
Marimaca Copper Corp. appoints Vice President, Project and Vice President, Project Execution.
Forsys Announces Appointment of Director
September 04, 2024 17:00 ET
|
Forsys Metals Corp
TORONTO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Forsys Metals Corp. (TSX: FSY) (FSE: F2T) (NSX: FSY) (“Forsys” or the “Company”) is pleased to announce the appointment of Pierfranco Malpenga as a member...
iSTAR Medical continues to strengthen US presence with appointment of Chief Medical Officer and Vice President of Clinical Affairs
September 04, 2024 07:00 ET
|
iSTAR Medical
For immediate release iSTAR Medical continues to strengthen US presence with appointment of Chief Medical Officer and Vice President of Clinical Affairs WAVRE, Belgium — 4 September 2024: iSTAR...
Harness Therapeutics Appoints Experienced R&D Executive and Physician-Scientist, Dr Paulo Fontoura, as Non-Executive Director
September 04, 2024 03:00 ET
|
Harness Therapeutics
Dr Paulo Fontoura brings 20 years’ experience of working in the pharma industry, with the most recent 16 years focusing on translational medicine and clinical development approaches for one of the...
Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
September 03, 2024 07:00 ET
|
Amphista Therapeutics
Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer The appointment will accelerate the Company’s next phase of growth, advancing its next generation Targeted Glue™ protein...
Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
September 03, 2024 03:00 ET
|
Amphista Therapeutics
Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer The appointment will accelerate the Company’s next phase of growth, advancing its next generation Targeted Glue™ protein...
Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
August 27, 2024 07:00 ET
|
Memo Therapeutics AG
PRESS RELEASE Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy Seasoned commercial leader with significant international experience Joins ahead of lead development candidate...
Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
August 27, 2024 02:00 ET
|
Memo Therapeutics AG
PRESS RELEASE Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy Seasoned commercial leader with significant international experience Joins ahead of lead development candidate...